RACHEL VOYLES: Open Payments
NPI 1407514276 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 18 payments from 9 companies in 2025. Trend: 2023 $1,082 · 2024 $726 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Ipsen Biopharmaceuticals, Inc | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
| Gilead Sciences, Inc. | 2 | $47 |
| Napo Pharmaceuticals Inc | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Ardelyx, Inc. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: IQIRVO, ENTYVIO, RINVOQ, MAVYRET, Mytesi, OCALIVA, IBSRELA, REZDIFFRA.
Industry payments across ND — which companies pay providers there.
